Federated Hermes, Inc. Veru Inc. Transaction History

Federated Hermes, Inc.

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 13, 2023	BUY	$0.72 - $1.33 $1,204 - $2,225	1,673 Added 87.87%	3,577 $2,000
Q2 2023 Aug 14, 2023	BUY	$0.98 - $1.49 $1,865 - $2,836	1,904 New	1,904 $2,000
Q4 2022 Feb 13, 2023	BUY	$4.78 - $15.01 $2,738 - $8,600	573 Added 40.78%	1,978 $10,000
Q3 2022 Nov 14, 2022	BUY	$10.22 - $23.7 $5,089 - $11,802	498 Added 54.91%	1,405 $16,000
Q2 2022 Aug 15, 2022	BUY	$4.35 - $15.85 $3,945 - $14,375	907 New	907 $10,000
Q4 2021 Feb 14, 2022	SELL	$5.89 - $9.73 $546,256 - $902,389	-92,743 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$6.78 - $9.89 $5.74 Million - $8.37 Million	-846,242 Reduced 90.12%	92,743 $791,000
Q2 2021 Aug 16, 2021	BUY	$7.24 - $11.2 $6.8 Million - $10.5 Million	938,985 New	938,985 $7.58 Million
Q3 2020 Nov 12, 2020	SELL	$2.58 - $3.36 $281 - $366	-109 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$3.01 - $4.02 $3,217 - $4,297	-1,069 Reduced 90.75%	109 $1,000
Q1 2020 May 13, 2020	BUY	$2.58 - $4.58 $3,039 - $5,395	1,178 New	1,178 $4,000

123

56.9M

668K

531K

Ticker VERU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 80,146,704
Market Cap $56.9M
Description
Veru Inc., an oncology biopharmaceutical company, focuses on developing medicines for the management of cancers. Its commercial products comprise FC2 female condom/internal condom for the dual protection against unintended pregnancy and the transmission of sexually transmitted infections for ministries of health, government health agencies, U.N....

Get notified when there are updates to the investment portfolio of Federated Hermes, Inc., based on Form 13F filings with the SEC.

Stay updated on Federated Hermes, Inc. with notifications on news.